Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Real-Time Price · USD

21.06

+0.31 (1.49%)

At close: Nov 4, 2026, 4:00 PM EST

21.99

+0.93 (4.42%)

After-hours: Nov 4, 2026, 7:58 PM EST

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	66,417	56,275	45,074	43,399	50,869	44,662
Market Cap Growth	58.18%	24.85%	3.86%	-14.68%	13.90%	-20.71%
Enterprise Value	97,593	86,263	78,050	75,918	81,755	74,563
Last Close Price	21.06	18.52	14.42	12.98	14.90	12.48

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	258.93	-	62.54	45.57	21.33	23.57
PS Ratio	2.22	1.99	1.47	1.54	1.68	1.52
PB Ratio	1.41	1.20	0.97	0.90	1.06	0.95
P/FCF Ratio	15.18	10.34	7.88	12.14	8.08	5.42
P/OCF Ratio	11.96	8.59	6.39	9.16	6.92	4.83

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	3.27	3.04	2.55	2.69	2.70	2.54
EV/EBITDA Ratio	11.22	11.10	9.48	9.33	8.46	7.65
EV/EBIT Ratio	19.74	22.57	20.76	22.85	17.54	15.09
EV/FCF Ratio	22.30	15.85	13.65	21.23	12.99	9.06

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.72	0.74	0.73	0.75	0.77	0.85
Debt / EBITDA Ratio	3.78	4.26	3.96	4.44	3.79	4.07
Debt / FCF Ratio	7.73	6.33	5.94	10.10	5.81	4.81
Net Debt / Equity Ratio	0.67	0.66	0.68	0.69	0.68	0.70
Net Debt / EBITDA Ratio	3.61	3.95	3.81	4.07	3.37	3.35
Net Debt / FCF Ratio	7.13	5.64	5.49	9.25	5.17	3.96
Asset Turnover	0.32	0.30	0.31	0.29	0.30	0.27
Inventory Turnover	1.21	1.24	1.30	1.30	1.36	1.40
Quick Ratio	0.51	0.52	0.44	0.50	0.49	0.73
Current Ratio	1.15	1.09	1.01	1.11	0.97	1.21
Return on Equity (ROE)	0.56%	-2.12%	1.52%	2.12%	5.27%	4.24%
Return on Assets (ROA)	3.27%	2.55%	2.40%	2.16%	2.85%	2.88%
Return on Invested Capital (ROIC)	6.22%	5.08%	2.91%	4.38%	5.15%	4.82%
Return on Capital Employed (ROCE)	6.10%	4.80%	4.80%	3.90%	5.40%	5.40%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Earnings Yield	0.39%	-1.70%	1.60%	2.20%	4.69%	4.24%
FCF Yield	6.59%	9.67%	12.69%	8.24%	12.37%	18.44%
Dividend Yield	2.34%	3.53%	4.57%	4.49%	4.14%	5.15%
Payout Ratio	605.34%	-	280.28%	199.34%	88.14%	123.30%
Buyback Yield / Dilution	1.27%	1.88%	-1.58%	-0.67%	0.46%	-0.23%
Total Shareholder Return	3.60%	5.42%	2.99%	3.83%	4.60%	4.92%

SEC Filings: 10-K · 10-Q